AXL and cancer: Analysis of the Pan-Cancer dataset integrating International Cancer Genome Consortium (ICGC) and The Cancer Genome Atlas (TCGA) [25] further revealed a significant correlation between FRA1 levels and AXL, CDK6, and FSCN1 expression in 1210 tumor samples of all cancer types (Fig. 5I).